New Results
Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor resistant HER2-positive breast cancer
Qingfei Wang, Ian H. Guldner, Samantha M. Golomb, Longhua Sun, Jack Harris, Xin Lu, View ORCID ProfileSiyuan Zhang
doi: https://doi.org/10.1101/671198
Qingfei Wang
1Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, IN 46556, USA
2Mike and Josie Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA
Ian H. Guldner
1Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, IN 46556, USA
2Mike and Josie Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA
Samantha M. Golomb
1Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, IN 46556, USA
2Mike and Josie Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA
Longhua Sun
1Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, IN 46556, USA
2Mike and Josie Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA
Jack Harris
1Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, IN 46556, USA
2Mike and Josie Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA
Xin Lu
1Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, IN 46556, USA
2Mike and Josie Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA
3The Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA
Siyuan Zhang
1Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, IN 46556, USA
2Mike and Josie Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA
3The Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA
Article usage
Posted June 14, 2019.
Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor resistant HER2-positive breast cancer
Qingfei Wang, Ian H. Guldner, Samantha M. Golomb, Longhua Sun, Jack Harris, Xin Lu, Siyuan Zhang
bioRxiv 671198; doi: https://doi.org/10.1101/671198
Subject Area
Subject Areas
- Biochemistry (11740)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17410)
- Clinical Trials (138)
- Developmental Biology (9420)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12239)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28070)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)